Oncology/Hematology
Anemia
More in Anemia
Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment
Mar 12, 2024
Lifetime reduction in acute pain episodes should offset high upfront costs of the therapy
Jan 22, 2024
In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly
Sep 18, 2023
An analysis of the ASPREE trial showed 100-mg aspirin led to more anemia events vs placebo
Jun 19, 2023
1.00
CME Credits